Behavioral pharmaceutical care scale for measuring pharmacists’ activities

Provision of pharmaceutical care by community pharmacists: a comparison across Europe

“…Orthogonal rotation was chosen since BPCS domains were hypothesized to be uncorrelated when the scale was first developed [4]. In addition, Scree test suggested the retention of 4 factors (Fig.…”

“…The questionnaire consisted of two sections; Section A contained 15 questions largely related to demographic information and services provided in the pharmacy; Section B had 34 questions and was a slightly adapted version of the BPCS [4,13] to account for differences in practice across countries. The latter scale contains three dimensions: direct care activities, referral and consultation activities and instrumental activities.…”

“…In addition to pharmacists' commitment and effort, several changes in the organization of pharmacists' work and payment systems are, however, required for implementation of pharmaceutical care to be realised [1,[4][5][6]. These include dealing with workplace issues such as heavy workload [7] and reimbursement systems, which are traditionally based on the number of products dispensed rather than on providing a holistic service [8].…”

“…Their results led the authors to conclude that pharmaceutical care, in its fullest sense, as defined in policy documents in Denmark, was not evident in practice. An earlier measure, known as the Behavioral Pharmaceutical Care Scale (BPCS), was developed by Odedina and Segal [4] in the United States (US) to measure the perceived provision of pharmaceutical care through assessing a pharmacist's recent behavioural activities. This scale (slightly modified) was used to investigate the extent of implementation of various aspects of pharmaceutical care in community pharmacy in Northern Ireland in 1996 [13].…”

The effect of pharmacist education on asthma treatment plans for simulated patients

“…Before the phone call, pharmacists completed a self-evaluation of their behavior and motivation to provide pharmaceutical care for patients with asthma (Behavioural Pharmaceutical Care Scale [BPCS] modified only by changing all general statements on chronic disease to specific statements on asthma) [21]. The results of this self-evaluation were used to structure and discuss any individual issues the pharmacists may have faced when trying to provide better care for patients with asthma at their practice sites.…”